Non-invasive tracking of CD4+ T cells with a paramagnetic and fluorescent nanoparticle in brain ischemia

Wei-Na Jin1, Xiaoxia Yang2, Zhiguo Li3

  • 1Departments of Neurology, Immunology, Radiology, Key Laboratory of Neurorepair and Regeneration, Tianjin and Ministry of Education, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.

Insights

Researchers developed a novel in vivo imaging method to track CD4(+) T cells in experimental ischemic stroke. This technique allows for non-invasive monitoring of these crucial immune cells in the brain and peripheral organs.

Area of Science:

  • Neuroscience
  • Immunology
  • Medical Imaging

Background:

  • Lymphocytes are critical in ischemic brain injury.
  • Non-invasive tracking of lymphocytes in the inflamed central nervous system (CNS) remains challenging.
  • Understanding lymphocyte dynamics is key to developing new therapies for CNS inflammatory diseases.

Purpose of the Study:

  • To develop and validate an in vivo imaging approach for sequential monitoring of CD4(+) T cells in experimental ischemic stroke.
  • To assess the feasibility of using magnetic resonance imaging (MRI) or Xenogen imaging combined with SPIO-Molday ION Rhodamine-B (MIRB) labeling for tracking these cells.
  • To investigate the spatiotemporal dynamics of brain-infiltrating CD4(+) T cells.

Main Methods:

  • Labeling of CD4(+) T cells with SPIO-Molday ION Rhodamine-B (MIRB).
  • In vivo imaging using MRI or Xenogen imaging for longitudinal monitoring.
  • Passive transfer model in experimental ischemic stroke.
  • Immunostaining of tissue sections for validation.

Main Results:

  • MIRB-labeled CD4(+) T cells were successfully visualized in the mouse brain using in vivo imaging.
  • Longitudinal monitoring revealed the dynamics of CD4(+) T cells in the brain, spleen, and liver after cerebral ischemia.
  • In vivo observations correlated well with ex vivo immunostaining data, confirming the accuracy of the tracking method.

Conclusions:

  • The combination of MIRB labeling and in vivo imaging provides a valid method for tracking CD4(+) T cells in ischemic brain injury.
  • This approach enables the study of spatiotemporal dynamics of brain-infiltrating lymphocytes in CNS inflammatory conditions.
  • Facilitates future research into the role of lymphocytes in neurological diseases.

Related Concept Videos